Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1997296 · no price history on file
Price series unavailable — No prices available for MDCXW in [1900-01-01, 2026-07-31]. This symbol may require bring-your-own-key (BYOK) data.
| Days to cover2.8d |
Short interest is FINRA semi-monthly, settlement 2026-07-15.
MDCXW is not in the screener universe.
No return windows available for MDCXW.
No risk analytics available for MDCXW.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| ARMISTICE CAPITAL, LLC | 60,600 | $57,564 | — | +0.0% |
| Anson Funds Management LP | 84,800 | $38,924 | — | +100.0% |
| Private Advisor Group, LLC | 49,000 | $27,445 | — | +0.0% |
| Empery Asset Management, LP | 12,100 | $11,494 | — | +0.0% |
| Connective Capital Management, LLC | 6,000 | $3,361 | — | +0.0% |
| UBS Group AG | 1,465 | $820 | — | new |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding not shown: no SEC cover-page share count falls within 120 days of the 2026-Q1 quarter end, so any percentage would rest on a count that cannot speak for this quarter. Holder share counts are shown as filed.
No reported quarters on file for MDCXW.
